← Open Payments lookup

KAMEKA HART: Open Payments

NPI 1528611662 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$671 in 23 payments from 8 companies in 2025. Trend: 2023 $7,635 · 2024 $387 · 2025 $671

Food & beverage: $671
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.4$194
Janssen Pharmaceuticals, Inc4$162
Neurocrine BioSciences, Inc.8$149
E.R. Squibb & Sons, L.L.C.2$57
Otsuka America Pharmaceutical, Inc.2$54
Indivior Inc.1$26
Alkermes, Inc.1$15
Braeburn Inc.1$14

Products named: INVEGA SUSTENNA, INGREZZA, UZEDY, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR, SUBLOCADE, LYBALVI.

Industry payments across DE — which companies pay providers there.